PVI
CABA icon

Pura Vida Investments’s Cabaletta Bio CABA Stock Holding History

Pura Vida Investments’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-154,792
Closed -$2.16M – 100
2019
Q4 		$2.16M Buy
+154,792
New +$1.83M 0.19% 78

Other funds holding CABA

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pura Vida Investments's CABA Position: Q1 2020 in Review

Pura Vida Investments sold out of Cabaletta Bio (CABA) in Q1 2020, closing a stake of 154,792 shares — an estimated $2.16M sold.

Pura Vida Investments first reported a position in CABA in Q4 2019 and held it in 1 quarter. The position peaked at $2.16M in Q4 2019. 41 funds tracked by Wall St. Rank hold CABA as of Q1 2020.

  • Pura Vida Investments reported no remaining Cabaletta Bio position as of Q1 2020 after selling out during the quarter.
  • Pura Vida Investments sold 154,792 Cabaletta Bio shares in Q1 2020, an estimated $2.16M.
  • Pura Vida Investments first reported a position in Cabaletta Bio in Q4 2019 and held it in 1 quarter.
  • Pura Vida Investments's Cabaletta Bio position peaked at $2.16M in Q4 2019.
  • 41 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2020.

Based on Pura Vida Investments's 13F filing for Q1 2020, filed 15 May 2020.